Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?

Muhannad Aboud Abbasi; Edward El-Am; Jeffrey B. Geske; Joerg Herrmann

doi:10.1016/j.mayocp.2023.12.013

Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?

Muhannad Aboud Abbasi, Edward El-Am, Jeffrey B. Geske, Joerg Herrmann

Cardiovascular Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	191-193
Number of pages	3
Journal	Mayo Clinic proceedings
Volume	99
Issue number	2
DOIs	https://doi.org/10.1016/j.mayocp.2023.12.013
State	Published - Feb 2024

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2023.12.013

Cite this

@article{3a072d851560480db95799294c2015c0,

title = "Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?",

author = "Abbasi, {Muhannad Aboud} and Edward El-Am and Geske, {Jeffrey B.} and Joerg Herrmann",

year = "2024",

month = feb,

doi = "10.1016/j.mayocp.2023.12.013",

language = "English (US)",

volume = "99",

pages = "191--193",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "2",

}

TY - JOUR

T1 - Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies

T2 - Is Hypertrophic Cardiomyopathy Any Different?

AU - Abbasi, Muhannad Aboud

AU - El-Am, Edward

AU - Geske, Jeffrey B.

AU - Herrmann, Joerg

PY - 2024/2

Y1 - 2024/2

UR - http://www.scopus.com/inward/record.url?scp=85183528030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85183528030&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2023.12.013

DO - 10.1016/j.mayocp.2023.12.013

M3 - Editorial

C2 - 38309931

AN - SCOPUS:85183528030

SN - 0025-6196

VL - 99

SP - 191

EP - 193

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 2

ER -

Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this